arrow
S

Stefania Chiappini

University of Catania
H指数:34
被引数:3,236

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Real-world effectiveness and tolerability of desvenlafaxine in major depressive disorder: A multicentre prospective Italian national-cohort study

度洛西汀在重度抑郁症中的真实世界有效性与耐受性:一项多中心前瞻性意大利国家队列研究

2026-09-010
PRE
Signal Detection of Depression and Suicidality Associated with Finasteride and Dutasteride: Updated Pharmacovigilance Evidence and Recommendations for Comprehensive Psychiatric Assessment

非那雄胺和多沙唑嗪相关的抑郁和自杀倾向信号检测:更新的药物警戒证据及全面的精神性评估建议

2026-04-060
OAAI
Possible Eye Disorders in Children Prenatally Exposed to Either Methadone or Buprenorphine in Comparison with Other Medications; An Examination of the Food and Drug Administration (FDA) Pharmacovigilance Database

孕期接触美沙酮或丁丙诺啡的儿童可能出现的眼部疾病与其他药物的对比研究;对食品药品监督管理局(FDA)药物警戒数据库的考察

2026-03-030
OAAI
Exploring Dual Diagnoses: Psychopathological Characteristics in the Co-Occurrence of Schizophrenia and Addiction - A Scoping Review

探索双重诊断:精神分裂症与成瘾共病的精神病理学特征——一项范围综述

2025-09-010
PRE
Efficacy and Tolerability of Vortioxetine Versus Selective Serotonin Reuptake Inhibitors for Late-Life Depression: A Post-hoc Analysis of the VESPA Study

沃瑞替酮与选择性5-羟色胺再摄取抑制剂治疗老年抑郁症的疗效与耐受性:VESPA研究的后验分析

2025-07-180
OAAI
EXPLORING VORTIOXETINE COMBINATION WITH INTRANASAL ESKETAMINE: A PROMISING ALTERNATIVE TO SSRI/SNRI - INSIGHTS FROM THE REAL-ESK STUDY

探索沃地文台汀与鼻腔内 esketamine 联合治疗:SSRI/SNRI 的一种有前景的替代方案——来自 REAL-ESK 研究的见解

2025-02-120
OA
EXAMINING LURASIDONE EFFICACY IN SCHIZOPHRENIC PATIENTS WITH COMORBID ALCOHOL AND SUBSTANCE USE DISORDER: A MULTICENTRIC PROSPECTIVE INVESTIGATION

评估拉帕西酮在伴有酒精和物质使用障碍的 schizophrenic 患者中的疗效:一项多中心前瞻性研究

2025-02-120
OA
RTMS OVER THE DORSOLATERAL PREFRONTAL CORTEX INCREASES THE SERUM PROBDNF/BDNF RATIO: A SHAM-CONTROLLED STUDY IN SUBJECTS WITH COCAINE USE DISORDER

重复经颅磁刺激作用于背外侧前额叶皮层增加了血清ProBDNF/BDNF比率:一项在可卡因使用障碍患者中的假对照研究

2025-02-120
OA